Novartis launches SMS for Life 2.0 to help improve access to essential medicines
Novartis announced today the launch of an innovative technology-based healthcare program called…
EC approves subcutaneous route of administration in Sandoz biosimilar, Binocrit
Sandoz, a Novartis division and the global leader in biosimilars, announced today…
